{
    "eid": "2-s2.0-85111767841",
    "title": "Influence of SULT1A1*2 polymorphism on plasma efavirenz concentration in thai HIV-1 patients",
    "cover-date": "2021-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Molecular Medicine",
            "@code": "1313",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "Efavirenz",
        "HIV-1",
        "Phase II drug-metabolizing enzymes",
        "Thai",
        "Transporter genes"
    ],
    "authors": [
        "Monpat Chamnanphon",
        "Rattanaporn Sukprasong",
        "Andrea Gaedigk",
        "Weerawat Manosuthi",
        "Pajaree Chariyavilaskul",
        "Supeecha Wittayalertpanya",
        "Napatrupron Koomdee",
        "Thawinee Jantararoungtong",
        "Apichaya Puangpetch",
        "Chonlaphat Sukasem"
    ],
    "citedby-count": 1,
    "ref-count": 66,
    "ref-list": [
        "Association of HCV and Treponema pallidum infection in HIV infected northeastern Thai male blood donors",
        "Decline in the AIDS and death rates in the EuroSIDA study: an observational study",
        "Improving HIV infection management using antiretroviral plasma drug levels monitoring: a clinician\u2019s point of view",
        "Relationship between antiretroviral plasma concentration and emergence of HIV-1 resistance mutations at treatment failure",
        "Efavirenz plasma levels for the prediction of treatment failure in heavily pretreated HIV-1 infected patients",
        "Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients",
        "The role of therapeutic drug monitoring in the management of patients with human immunodefi-ciency virus infection",
        "Efavirenz plasma concentrations in HIV-infected patients: inter-and intraindividual variability and clinical effects",
        "Pharmacogenetics-based population pharmacokinetic analysis of efavirenz in HIV-1-infected individuals",
        "Influence of the cyto-chrome P450 2B6 genotype on population pharmacokinetics of efa-virenz in human immunodeficiency virus patients",
        "Population pharmacoki-netics and effects of efavirenz in patients with human immunodefi-ciency virus infection",
        "Presence of the CYP2B6 516G> T polymorphism, increased plasma Efavirenz concentrations and early neuropsychiatric side effects in South African HIV-infected patients",
        "Population pharmacokinetic/ pharmacogenetic model for optimization of efavirenz therapy in Caucasian HIV-infected patients",
        "Impact of CYP2B6 polymorphism on hepatic efavirenz metabolism in vitro",
        "High plasma efavirenz concentration and CYP2B6 polymorphisms in Thai HIV-1 infections",
        "Effect of CYP2B6 gene polymorph-isms on efavirenz plasma concentrations in Chinese patients with HIV infection",
        "The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavir-enz primary and secondary metabolism: implication for HIV/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity",
        "Efavirenz primary and secondary metabolism in vitro and in vivo: identification of novel metabolic pathways and cyto-chrome P450 2A6 as the principal catalyst of efavirenz 7-hydroxylation",
        "Identification and char-acterization of efavirenz metabolites by liquid chromatography/ mass spectrometry and high field NMR: species differences in the metabolism of efavirenz",
        "Identification of human UGT isoforms responsible for glucuronidation of efavirenz and its three hydroxy metabolites",
        "Glucuronidation of the antiretroviral drug efavirenz by UGT2B7 and an in vitro investigation of drug-drug interaction with zidovudine",
        "Gene-gene interactions between DRD3, MRP4 and CYP2B6 polymorphisms and its influence on the pharmacokinetic parameters of efavirenz in HIV infected patients",
        "The human multidrug resistance protein 4 (MRP4, ABCC4): functional analysis of a highly polymorphic gene",
        "Secondary metabolism path-way polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes",
        "Pharmacogenetic associations with plasma efavirenz concentrations and clinical correlates in a retrospective cohort of Ghanaian HIV-infected patients",
        "Influence of host genetic factors on efavirenz plasma and intracellular pharmacokinetics in HIV-1-infected patients",
        "Correlates of efavirenz exposure in Chilean patients affected with human immunodeficiency virus reveals a novel association with a polymorphism in the constitutive androstane receptor",
        "Pharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV-1 infected Thai adults",
        "Low level of efavirenz in HIV-1-infected Thai adults is associated with the CYP2B6 polymorphism",
        "CYP2D6, SULT1A1 and UGT2B17 copy number variation: quantitative detection by multiplex PCR",
        "Effects of SULT1A1 copy number variation on estrogen concentration and tamoxifen-associated adverse drug reactions in premenopausal Thai breast cancer patients: a preliminary study",
        "Human SULT1A1 gene: copy number differences and functional implications",
        "Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolism",
        "Methyleugenol DNA adducts in human liver are associated with SULT1A1 copy number variations and expression levels",
        "SULT1A1 copy number variation: ethnic distribution analysis in an Indian population",
        "Copy number variation in sulfo-transferase isoform 1A1 (SULT1A1) is significantly associated with enzymatic activity in Japanese subjects",
        "Abstract 2857: SULT1A1 gene copy number variations and functional polymorphism in relation to breast cancer risk",
        "Copy number variation in Thai population",
        "Genome-wide copy-number-variation study identified a susceptibility gene, UGT2B17, for osteoporosis",
        "Homozygous deletions of UGT2B17 modifies effects of smoking on TP53-mutations and relapse of head and neck carcinoma",
        "The effect of copy number variation in the phase II detoxification genes UGT2B17 and UGT2B28 on colorectal cancer risk",
        "Homozygous deletion of the UGT2B17 gene is not associated with osteoporosis risk in elderly Caucasian women",
        "UGT2B17 copy number gain in a large ankylosing spondylitis multiplex family",
        "Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2B6 and efavirenz-containing antiretroviral therapy",
        "Functional genetic variants in the 3\u02b9-untranslated region of sulfotransferase isoform 1A1 (SULT1A1) and their effect on enzymatic activity",
        "Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism",
        "Sulfation pharma-cogenetics: SULT1A1 and SULT1A2 allele frequencies in Caucasian, Chinese and African-American subjects",
        "Single nucleotide polymorphisms in SULT1A1 and SULT1A2 in a Korean population",
        "Frequency distribution of phenol sulfotransferase 1A1 activity in platelet cells from healthy Japanese subjects",
        "Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype",
        "Human phenol sulfo-transferases SULT1A2 and SULT1A1: genetic polymorphisms, allo-zyme properties, and human liver genotype-phenotype correlations",
        "Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransfer-ase 1A1, catechol-o-methyltransferase and tobacco exposure in breast cancer risk",
        "Sulfotransferase 1A1 genotype as a potential modifier of breast cancer risk among preme-nopausal women",
        "Genetic polymorphisms in human SULT1A1 and UGT1A1 genes associate with breast tumor characteristics: a case-series study",
        "Human SULT1A1 gene: copy number differences and functional implications",
        "Sulfation of fulvestrant by human liver cytosols and recombinant SULT1A1 and SULT1E1",
        "Sulfation of 4-hydroxy toremifene: individual variability, isoform specificity, and contribution to toremifene pharmacogenomics",
        "Pharmacogenetic-based efavirenz dose modification: suggestions for an African population and the different CYP2B6 genotypes",
        "Multidrug resistance-associated proteins 3, 4, and 5",
        "Mrp4 confers resistance to topotecan and protects the brain from chemotherapy",
        "Impact of pharma-cogenetics on CNS side effects related to efavirenz",
        "Surveillance of genotypic resistance mutations in chronic HIV-1 treated individuals after completion of the National Access to Antiretroviral Program in Thailand",
        "Pharmacogenetics and clinical biomarkers for subtherapeutic plasma efavirenz concentration in HIV-1 infected Thai adults",
        "Substantial effect of efavir-enz monotherapy on bilirubin levels in healthy volunteers",
        "High plasma efavirenz level and CYP2B6*6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naive HIV patients from Ethiopia: a prospective cohort study",
        "Copy number variations exploration of multiple genes in Graves\u2019 disease"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Kansas City",
            "@id": "60020359",
            "affilname": "UMKC School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020359",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60015887",
            "affilname": "Faculty of Medicine Ramathibodi Hospital, Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015887",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nontaburi",
            "@id": "60015728",
            "affilname": "Thailand Ministry of Public Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015728",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60000316",
            "affilname": "Srinakharinwirot University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000316",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Kansas City",
            "@id": "114392415",
            "affilname": "Children's Mercy Kansas City",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/114392415",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "Division of Clinical Pharmacology",
        "International Research Network-The Thailand Research Fund",
        "School of Medicine, University of Missouri?Kansas City",
        "Children?s Mercy Kansas City",
        "Chulalongkorn University",
        "Mahidol University"
    ]
}